Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v5-EN
Language English English
Date Updated 2019-12-14 2019-12-13
Drug Identification Number 02474271 02474271
Brand name METOPROLOL TARTRATE INJECTION USP METOPROLOL TARTRATE INJECTION USP
Common or Proper name Metoprolol Tartrate Injection USP Metoprolol Tartrate Injection USP
Company Name JUNO PHARMACEUTICALS CORP. JUNO PHARMACEUTICALS CORP.
Ingredients METOPROLOL TARTRATE METOPROLOL TARTRATE
Strength(s) 1MG 1MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 10
ATC code C07AB C07AB
ATC description BETA BLOCKING AGENTS BETA BLOCKING AGENTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2019-10-31 2019-10-31
Actual start date 2019-08-29 2019-08-29
Estimated end date 2019-12-06 2019-12-06
Actual end date 2019-12-13 2019-12-13
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Resolved Resolved
Health Canada comments